NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.940
+0.050 (5.62%)
At close: Nov 6, 2024, 4:00 PM
0.960
+0.020 (2.13%)
Pre-market: Nov 7, 2024, 7:19 AM EST
NMTC Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for NMTC.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for NMTC.
Recommendation Trends
Rating | May '23 | Jun '23 | Jul '23 | Aug '23 |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $3.25 → $2.2 | Strong Buy | Maintains | $3.25 → $2.2 | +134.04% | Aug 15, 2023 |
Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 28, 2022 |
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +538.30% | Nov 15, 2021 |
Financial Forecast
Revenue This Year
7.14M
from 3.41M
Increased by 109.53%
Revenue Next Year
13.57M
from 7.14M
Increased by 90.00%
EPS This Year
-0.43
from -0.65
EPS Next Year
-0.29
from -0.43
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 7.4M | 14.0M |
Avg | 7.1M | 13.6M |
Low | 6.9M | 13.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | 115.7% | 95.6% |
Avg | 109.5% | 90.0% |
Low | 101.3% | 82.5% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -0.44 | -0.29 |
Avg | -0.43 | -0.29 |
Low | -0.41 | -0.27 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.